Cargando…
Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma
BACKGROUND: Glioblastoma multiforme (GBM) is the most malignant primary tumor of the central nervous system and is associated with a very poor prognosis. No further improvements in outcomes have been reported since radiotherapy-temozolomide therapy was introduced. Therefore, developing new agents to...
Autores principales: | Wang, Rong, Deng, Danni, Shao, Naiyuan, Xu, Yuan, Xue, Lian, Peng, Ya, Liu, Yatian, Zhi, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841348/ https://www.ncbi.nlm.nih.gov/pubmed/29535541 http://dx.doi.org/10.2147/OTT.S155275 |
Ejemplares similares
-
Luteolin suppresses tumor proliferation through inducing apoptosis and autophagy via MAPK activation in glioma
por: You, Yijie, et al.
Publicado: (2019) -
Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells
por: Hong, Zhong, et al.
Publicado: (2020) -
Upregulation of SIRT1 by Evodiamine activates PI3K/AKT pathway and blocks intervertebral disc degeneration
por: Kuai, Jianbo, et al.
Publicado: (2022) -
Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models
por: Pang, Shuo, et al.
Publicado: (2023) -
Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
por: Wei, Wei-Tian, et al.
Publicado: (2011)